附件肿物影像学当代指南:2020年更新
本文针对超声、CT和MRI偶然发现的附件肿物,综述了四份近年共识文件:ACR 2020 CT/MRI偶发附件发现管理更新、SRU 2019单纯附件囊肿共识更新、O-RADS超声(2020)和O-RADS MRI(2020)风险分层系统,以帮助将病灶归类为良性、不确定或可能恶性。
要点
- 四份文件分别覆盖CT/MRI偶发附件发现管理、单纯囊肿、超声O-RADS和MRI O-RADS风险分层。
- 准确无创风险分层是避免不必要卵巢切除术导致个人和经济负担的关键。
- 各系统目标是将附件肿物归为良性、不确定或可能恶性以指导管理。
核心结论
- 本文简要综述了四份近期发布的附件肿物分层系统,用于将偶然发现的附件肿物归为良性、不确定或可能恶性。
研究设计与样本
- 本文为综述,汇总ACR 2020 CT/MRI偶发附件发现管理更新、SRU 2019单纯附件囊肿共识更新、O-RADS超声(2020)和O-RADS MRI(2020)四份文件。
诊断标准与关键数值
- 四份文件均旨在将附件肿物归类为良性、不确定或可能恶性,原文未给出具体阈值或数值。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Incidental adnexal masses are commonly encountered at ultrasound, computed tomography, and magnetic resonance imaging. Since many of these lesions are surgically resected and ultimately found to be benign, patients may be exposed to personal and economic costs related to unnecessary oophorectomy. Thus, accurate non-invasive risk stratification of adnexal masses is essential for optimal management and outcomes. Multiple consensus guidelines in radiology have been published to assist in characterization of these masses as benign, indeterminate, or likely malignant. In the last two years, several new and updated stratification systems for assessment of incidental adnexal masses have been published. The purpose of this article is to offer a concise review of four recent publications: ACR 2020 update on the management of incidental adnexal findings on CT and MRI, SRU 2019 consensus update on simple adnexal cysts, O-RADS ultrasound risk stratification system (2020), and O-RADS MRI risk stratification system (2020).
引用
- Stein EB, Roseland ME, Shampain KL, et al. Contemporary Guidelines for Adnexal Mass Imaging: A 2020 Update. Abdom Radiol (NY). 2020. PMID: 33079254. doi:10.1007/s00261-020-02812-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。